EcoR1 Capital’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.57M | Hold |
27,404,070
| – | – | 0.39% | 29 |
|
|
2025
Q1 | $5.4M | Hold |
27,404,070
| – | – | 0.32% | 30 |
|
|
2024
Q4 | $14.8M | Hold |
27,404,070
| – | – | 0.56% | 32 |
|
|
2024
Q3 | $26M | Hold |
27,404,070
| – | – | 0.89% | 27 |
|
|
2024
Q2 | $26.7M | Hold |
27,404,070
| – | – | 0.82% | 26 |
|
|
2024
Q1 | $43.3M | Buy |
+27,404,070
| New | +$43.3M | 1.1% | 22 |
|